$ACT News Intuitive Surgical slumps; Facebook extends

New Post Public Reply Private Reply Replies (0) Message Board

Apr 11, 2014 at 8:51 PM

$ACT News

Intuitive Surgical slumps; Facebook extends rally 3:41 p.m. April 9, 2014 - Saumya Vaishampayan
Actavis acquires Silom Medical for $100 million 10:19 a.m. April 1, 2014 - MarketWatch.com
The 10 most overbought stocks in the S&P 500 index 12:19 p.m. March 25, 2014 - The Trading Deck
UK drug rejection, patent concerns take a bite out of Celgene shares 1:33 p.m. March 14, 2014 - blogs.marketwatch.com
Mylan to start selling generic Celebrex in May 7:22 a.m. March 13, 2014 - MarketWatch.com
Pfizer loses Celebrex patent ruling; shares halted but effect muted 3:21 p.m. March 12, 2014 - blogs.marketwatch.com
Staples awash in red; eBay up as Icahn posts new letter 4:09 p.m. March 6, 2014 - Victor Reklaitis
Icahn Enterprises reports profit up 144% in 2013 10:22 a.m. March 3, 2014 - MarketWatch
Citadel hedge fund’s recent moves 11:12 a.m. Feb. 25, 2014 - Insider Monkey
Stocks rally; S&P 500 ends right below record 4:45 p.m. Feb. 24, 2014 - Victor Reklaitis
U.S. stock market is starting to ride a tech M&A wave 5:31 a.m. Feb. 24, 2014 - Wallace Witkowski
Actavis continues hot streak with better-than-expected earnings 11:21 a.m. Feb. 20, 2014 - blogs.marketwatch.com
Actavis swings to loss on charges, write-downs 8:03 a.m. Feb. 20, 2014 - MarketWatch.com
Pharma megamergers bring higher profits, better returns, study says 1:59 p.m. Feb. 19, 2014 - blogs.marketwatch.com
Actavis, Forest shares continue their climb in aftermath of $25 billion deal 11:03 a.m. Feb. 19, 2014 - blogs.marketwatch.com
U.S. stocks edge up; Nasdaq gains for 8th day in a row 4:38 p.m. Feb. 18, 2014 - Anora Mahmudova
Forest Laboratories, Actavis surge on buyout deal 4:10 p.m. Feb. 18, 2014 - Ben Eisen
S&P 500, Nasdaq extend win streaks but Dow dips: stock market live blog recap 4:06 p.m. Feb. 18, 2014 - blogs.marketwatch.com
Forest buyout may not spell the end of dealmaking for Actavis 3:00 p.m. Feb. 18, 2014 - blogs.marketwatch.com
Pharma ETFs pop on the Actavis-Forest deal 2:07 p.m. Feb. 18, 2014 - blogs.marketwatch.com

Acura Pharma Ends Agreement with Pfizer - Analyst Blog 5:35 p.m. Today - Zacks.com
Facebook, Arris, Grifols Initiate New Bases 5:35 p.m. Today - Investors Business Daily
3 Health Care Stocks Moving The Sector Upward 1:02 p.m. Today - TheStreet.com
Regulatory Update from Forest Labs - Analyst Blog 4:40 p.m. April 10, 2014 - Zacks.com
Actavis Becomes #157 Most Shorted S&P 500 Component, Replacing Vornado Realty Trust 3:19 p.m. April 10, 2014 - TheStreet.com
Buy Actavis - An Attractive Value And Growth Play That Is Also A Top Guru Fund Pick 12:27 a.m. April 10, 2014 - Seeking Alpha
Mallinckrodt plc (MNK) in Focus: Stock Moves 5.3% Higher - Tale of the Tape 8:37 a.m. April 9, 2014 - Zacks.com
Alexion, Biogen Among Leading Big-Cap Biotechs 7:02 a.m. April 9, 2014 - Investors Business Daily
Pacira and Patheon Collaborate - Analyst Blog 6:10 p.m. April 8, 2014 - Zacks.com
Additional Data on Pacira's Exparel - Analyst Blog 5:20 p.m. April 8, 2014 - Zacks.com
Should You Get Rid of Relypsa (RLYP) Now? - Tale of the Tape 8:44 a.m. April 7, 2014 - Zacks.com
Actavis PLC (ACT): Today's Featured Drugs Laggard 5:01 p.m. April 4, 2014 - TheStreet.com
Caesarstone, Other Leading Stocks Showing Supporting Action 4:49 p.m. April 4, 2014 - Investors Business Daily
Mylan Bid Gets Rejected, But Generic-Drugmaker Rises 4:28 p.m. April 4, 2014 - Investors Business Daily
3 Stocks Dragging The Drugs Industry Downward 1:02 p.m. April 4, 2014 - TheStreet.com
Mylan Rejected In Bid To Acquire Sweden's Meda 11:27 a.m. April 4, 2014 - Investors Business Daily
Mylan Eyes Swedish Drug Maker 10:12 p.m. April 3, 2014 - The Wall Street Journal Interactive Edition
Actavis Up Slightly on Silom Acquisition - Analyst Blog 3:56 p.m. April 3, 2014 - Zacks.com
Four Top World Stocks Offer Follow-On Buy Points 5:11 p.m. April 2, 2014 - Investors Business Daily
Pacira Up as Exparel Site Gets FDA Nod - Analyst Blog 6:00 p.m. April 1, 2014 - Zacks.com

Recent Acquisitions, Trial Opinions, Upcoming Earnings, Inducement Grants, and Clinical Trial Results - Analyst Notes on Actavis, The Medicines Company, Hospira, Horizon Pharma, and Galectin 8:00 a.m. Today - PR Newswire - PRF
Pharma Equities under Review -- Research on Mylan, Actavis, Hospira, and Medicines 12:30 p.m. April 10, 2014 - PR Newswire - PRF
Actavis Launches Asia Pacific Regional Headquarters in Singapore 8:00 p.m. April 2, 2014 - PR Newswire - PRF
Particle Sciences and Actavis Enter into Joint Development Agreement 11:00 a.m. April 1, 2014 - PR Newswire - PRF
Actavis Acquires Silom Medical Company 8:30 a.m. April 1, 2014 - PR Newswire - PRF
Actavis Completes Divestiture of Commercial Operations in Seven Western European Countries to Aurobindo Pharma Limited 8:00 a.m. April 1, 2014 - PR Newswire - PRF
Actavis Confirms Favorable Ruling in Generic Lialda® Patent Suit 4:05 p.m. March 28, 2014 - PR Newswire - PRF
Drug Approvals, Stock Price Movements, and New Tools for Standardization - Analyst Notes on Biogen Idec, Alexion, Actavis, Thermo Fisher Scientific, and Medtronic 8:00 a.m. March 26, 2014 - PR Newswire - PRF
Actavis and Valeant Announce FDA Approval for Metronidazole 1.3% 5:00 p.m. March 25, 2014 - PR Newswire - PRF
Actavis and Valeant Announce FDA Approval for Metronidazole 1.3% 5:00 p.m. March 25, 2014 - PR Newswire - PRF
Actavis to Host First Quarter 2014 Earnings Conference Call and Webcast 4:33 p.m. March 21, 2014 - PR Newswire - PRF
Pharmaceutical Equities under Review -- Research on Zoetis, Mylan, AVANIR Pharma and Actavis 11:11 a.m. March 21, 2014 - PR Newswire - PRF
Actavis Announces Daytrana® Patent Challenge Settlement 4:05 p.m. March 19, 2014 - PR Newswire - PRF
New Drug Applications, Earnings Release Schedules, Drug Designations, New Services, and Clinical Trials - Analyst Notes on Actavis, Intercept, GW Pharmaceuticals, Galena, and Conatus 8:00 a.m. March 13, 2014 - PR Newswire - PRF
Actavis Confirms Favorable Ruling in Generic Celebrex® Patent Suit 5:35 p.m. March 12, 2014 - PR Newswire - PRF
Columbia Laboratories Repurchases 1.4 Million Shares of Common Stock from Actavis 6:50 a.m. March 7, 2014 - PR Newswire - PRF
Actavis to Present at Barclays Global Healthcare Conference 8:00 a.m. March 4, 2014 - PR Newswire - PRF
Actavis Confirms Generic Colcrys® Patent Challenge 4:05 p.m. Feb. 28, 2014 - PR Newswire - PRF
Actavis Confirms Generic Multaq® Patent Challenge 8:00 a.m. Feb. 28, 2014 - PR Newswire - PRF
Actavis Net Revenue Increases 59% to $2.779 Billion in Fourth Quarter 2013; Non-GAAP EPS Increases 99% to $3.17 7:00 a.m. Feb. 20, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Biointron's RushDATA™: Speeding Up Antibody Discovery

A New Chapter in Antibody Discovery Well, color me intrigued. Biointron, a name you'd recognize if you've got even a toe in the biotech pond, just threw a serious curveball into the antibody discovery game with RushDATA™—an AI- and machine learning-driven platform that's packing a punch. And it's not just about throwing tech buzzwords around; this thing clocks...

First Horizon's $25M Bet: New Center Transforms Houston

New Markets Tax Credits: A Game Changer First things first, if you're thinking this is some typical charitable write-off, think again. First Horizon Bank (NYSE: FHN) is deep in the mix of something pretty transformative in the world of finance and community support. They're not just throwing money at a problem and hoping it sticks. Nope, we're talking real strategy with a...

When to Switch Your LLC to S Corp Status: Tips

Is Your LLC Ready for the S Corp Leap? Thinking about shifting your LLC to S corporation status? You're not alone—many business owners hit this fork in the road as their enterprise starts rolling in more dough. And if you're scratching your head wondering if this switch makes sense for your venture, listen up because timing and context are everything here. When Should...

Will Hair Loss Drugs Challenge Transplant Clinics?

Emerging Treatments Stir Up Hair Loss Scene You ever get the feeling we're on the brink of something big? That's where we are with hair loss treatments, folks. As of late 2026, new drugs are making waves in clinical trials, but they’re not yet giving hair transplant clinics any sleepless nights. Smile Hair Clinic's co-founders, Dr. Mehmet Erdo?an and Dr. Gökay Bilgin,...

SPOC Energy's Hiring Push Signals Growth Surge

A Growing Workforce for a Growing Demand Here we are, smack dab in a bustling week of business news, and among it, SPOC Energy is ramping up its workforce across Alabama. Now, SPOC isn't any run-of-the-mill operation; this Birmingham-based manufacturer messes around with advanced power conversion systems and motor-control automation—a mouthful, sure, but critical stuff...

Foreigner to Rock Irvine with Night Ranger in 2027

Irvine Set for a Rock Revival Talk about a blast from the past! On March 27, 2027, two titans of the rock world, Foreigner and Night Ranger, are set to ignite Irvine like it's the glory days of arena rock all over again. Hosted at the Great Park Live, this show isn't just a concert—it's a full-scale invasion of rock's golden age right into Southern California's heart....

Philip Scroggie's Legacy in Global Energy Projects

A Lifetime of Energy Industry Excellence When you've been around the block in the energy sector as long as Philip D. Scroggie has, you're bound to pick up a few accolades. Recognized as an Inner Circle Lifetime Member, this guy has etched his name in the annals of global energy project management. Yeah, he's been a heavyweight in the oil, gas, and LNG industries, and he's...

TruGreen Finds New Growth in Birch Hill Acquisition

TruGreen's New Chapter Begins In the world of lawn care, TruGreen is sowing the seeds for a revitalized future, courtesy of its recent acquisition by Birch Hill Equity Partners. Based out of Franklin, Tennessee, this powerhouse in the green arena is set to start a fresh chapter, swapping partners like old gloves after a long, 19-year stint with Clayton, Dubilier & Rice...

The Melt Expands with Key Texas Franchise Deal

Throwing Down the Gauntlet: The Melt Expands If there's one thing I've learned after decades watching these restaurant chains multiply like rabbits it’s this: when a veteran gets involved, you perk up. The Melt has done just that by roping in Syed Ahmad—a name that actually means something in this game—to open eight new locations in the Lone Star State. It isn't...

ADI Global Faces Investor Investigation Over Major Write-Down

Towering Goodwill Falls and Investor Scrutiny Well, let's dig into this mess ADI Global Distribution has found itself in. If you were hanging onto ADIG shares, your portfolio probably took quite the hit when they revealed a nasty $659 million goodwill write-down. Imagine opening up those financials and seeing about 62% of goodwill value wiped out overnight. Suddenly, that...